| Primary |
| Type 2 Diabetes Mellitus |
40.1% |
| Diabetes Mellitus |
17.0% |
| Product Used For Unknown Indication |
9.9% |
| Type 1 Diabetes Mellitus |
6.9% |
| Hypertension |
5.0% |
| Diabetes Mellitus Non-insulin-dependent |
4.8% |
| Diabetes Mellitus Insulin-dependent |
2.9% |
| Blood Pressure |
2.6% |
| Device Therapy |
2.5% |
| Drug Use For Unknown Indication |
1.7% |
| Depression |
1.0% |
| Insulin-requiring Type 2 Diabetes Mellitus |
0.9% |
| Prophylaxis |
0.8% |
| Hypothyroidism |
0.8% |
| Type Ii Diabetes Mellitus |
0.6% |
| Thyroid Disorder |
0.6% |
| Pain |
0.6% |
| Gastric Disorder |
0.5% |
| Diabetes |
0.5% |
| Cardiac Disorder |
0.5% |
|
| Device Malfunction |
35.6% |
| Product Quality Issue |
11.5% |
| Hypoglycaemia |
5.3% |
| Death |
5.1% |
| Hyperglycaemia |
4.7% |
| Visual Impairment |
3.9% |
| Blood Glucose Increased |
3.8% |
| Weight Increased |
3.6% |
| Myocardial Infarction |
3.0% |
| Weight Decreased |
2.7% |
| Vomiting |
2.6% |
| Cerebrovascular Accident |
2.6% |
| Pneumonia |
2.4% |
| Visual Acuity Reduced |
2.4% |
| Pharmaceutical Product Complaint |
2.3% |
| Renal Failure |
1.9% |
| Vision Blurred |
1.8% |
| Tremor |
1.7% |
| Hospitalisation |
1.6% |
| Loss Of Consciousness |
1.6% |
|
| Secondary |
| Type 2 Diabetes Mellitus |
38.0% |
| Diabetes Mellitus |
17.3% |
| Type 1 Diabetes Mellitus |
8.1% |
| Hypertension |
6.9% |
| Product Used For Unknown Indication |
6.7% |
| Diabetes Mellitus Non-insulin-dependent |
5.2% |
| Diabetes Mellitus Insulin-dependent |
3.2% |
| Drug Use For Unknown Indication |
2.9% |
| Depression |
1.8% |
| Blood Pressure |
1.6% |
| Insulin-requiring Type 2 Diabetes Mellitus |
1.5% |
| Device Therapy |
0.9% |
| Pain |
0.9% |
| Cardiac Failure |
0.8% |
| Prophylaxis |
0.8% |
| Asthma |
0.7% |
| Insomnia |
0.7% |
| Hypothyroidism |
0.7% |
| Diabetic Ketoacidosis |
0.7% |
| Hyperlipidaemia |
0.6% |
|
| Hypoglycaemia |
13.0% |
| Blood Glucose Increased |
10.2% |
| Hyperglycaemia |
8.8% |
| Product Quality Issue |
7.3% |
| Weight Decreased |
6.4% |
| Device Malfunction |
6.1% |
| Wrong Drug Administered |
6.1% |
| Weight Increased |
6.1% |
| Vomiting |
4.8% |
| Tremor |
3.4% |
| Vision Blurred |
3.3% |
| Visual Impairment |
3.1% |
| Myocardial Infarction |
2.9% |
| Renal Failure |
2.8% |
| Loss Of Consciousness |
2.7% |
| Syncope |
2.7% |
| Somnolence |
2.6% |
| Malaise |
2.5% |
| Nausea |
2.5% |
| Hypoglycaemic Unconsciousness |
2.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
27.3% |
| Diabetes Mellitus |
16.9% |
| Drug Use For Unknown Indication |
16.0% |
| Type 2 Diabetes Mellitus |
9.3% |
| Hypertension |
8.0% |
| Diabetes Mellitus Non-insulin-dependent |
3.0% |
| Pain |
2.7% |
| Type 1 Diabetes Mellitus |
2.7% |
| Depression |
2.0% |
| Prophylaxis |
1.7% |
| Blood Cholesterol Increased |
1.4% |
| Rheumatoid Arthritis |
1.4% |
| Cardiac Disorder |
1.1% |
| Gastrooesophageal Reflux Disease |
1.1% |
| Insulin-requiring Type 2 Diabetes Mellitus |
1.0% |
| Hepatitis C |
0.9% |
| Anxiety |
0.9% |
| Atrial Fibrillation |
0.9% |
| Asthma |
0.8% |
| Insomnia |
0.8% |
|
| Weight Decreased |
21.3% |
| Vomiting |
12.1% |
| Blood Glucose Increased |
8.9% |
| Nausea |
7.1% |
| Weight Increased |
7.1% |
| Myocardial Infarction |
4.6% |
| Drug Ineffective |
4.0% |
| Renal Failure Acute |
3.6% |
| Tremor |
3.3% |
| Death |
3.3% |
| Renal Failure |
3.0% |
| Pneumonia |
2.7% |
| Visual Acuity Reduced |
2.7% |
| Urinary Tract Infection |
2.6% |
| Pancreatitis |
2.6% |
| Pain |
2.4% |
| Hypoglycaemia |
2.4% |
| Vision Blurred |
2.2% |
| Off Label Use |
2.1% |
| Somnolence |
2.0% |
|
| Interacting |
| Hypertension |
26.9% |
| Depression |
15.3% |
| Cardiac Failure |
12.8% |
| Diabetes Mellitus |
9.6% |
| Anxiety |
8.6% |
| Infection |
6.3% |
| Product Used For Unknown Indication |
4.0% |
| Type 2 Diabetes Mellitus |
2.9% |
| Tachyarrhythmia |
2.8% |
| Drug Use For Unknown Indication |
2.6% |
| Type 1 Diabetes Mellitus |
1.8% |
| Dyslipidaemia |
1.4% |
| High Density Lipoprotein Decreased |
1.3% |
| Blood Cholesterol Increased |
1.1% |
| Glaucoma |
0.6% |
| Hypothyroidism |
0.6% |
| Chronic Obstructive Pulmonary Disease |
0.4% |
| Pneumonia |
0.4% |
| Pruritus Genital |
0.4% |
| Atrial Fibrillation |
0.3% |
|
| Mobility Decreased |
32.1% |
| Hypoglycaemia |
18.3% |
| Myocardial Infarction |
9.2% |
| Drug Interaction |
7.3% |
| Glycosylated Haemoglobin Increased |
5.5% |
| Aphasia |
4.6% |
| Vomiting |
3.7% |
| Somnolence |
2.8% |
| Tremor |
2.8% |
| Blood Glucose Fluctuation |
1.8% |
| Diabetic Ketoacidosis |
1.8% |
| Hypoglycaemic Unconsciousness |
1.8% |
| Pain In Extremity |
1.8% |
| Blood Glucose Decreased |
0.9% |
| Blood Glucose Increased |
0.9% |
| Flatulence |
0.9% |
| Hyperglycaemia |
0.9% |
| Palpitations |
0.9% |
| Self Injurious Behaviour |
0.9% |
| Shock Hypoglycaemic |
0.9% |
|
